Mechanoregulation of valvular interstitial cell phenotype in the third dimension

Biomaterials

Volumn 35, Issue 4, 2014, Pages 1128-1137

  Kural, Mehmet H ^a   Billiar, Kristen L ^a,b  

^a Worcester Polytechnic Institute   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

3D; Contraction; Heart valves; Stiffness; TGF 1; Valvular interstitial cells

Indexed keywords

3D; HEART VALVES; MEMBRANE DEPOLARIZATION; MULTIPLE REGRESSION MODEL; STIMULATE MATRIX PRODUCTION; THREE-DIMENSIONAL CULTURE SYSTEM; TISSUE-ENGINEERED HEART; TRANSFORMING GROWTH FACTORS;

BIOMATERIALS; CELLS; COLLAGEN; CYTOLOGY; MUSCULOSKELETAL SYSTEM; SHRINKAGE; STIFFNESS; STIFFNESS MATRIX; TISSUE; TISSUE REGENERATION;

BIOMECHANICS;

BIOMATERIAL; COLLAGEN; EPIDERMAL GROWTH FACTOR; FIBRIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; CELL INTERACTION; CONNECTIVE TISSUE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HEART VALVE; MEMBRANE DEPOLARIZATION; MYOFIBROBLAST; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; SWINE; TENSION; TISSUE ENGINEERING; VALVULAR INTERSTITIAL CELL;

3D; CONTRACTION; HEART VALVES; STIFFNESS; TGF-Β1; VALVULAR INTERSTITIAL CELLS;

ANIMALS; BIOMECHANICAL PHENOMENA; CELLS, CULTURED; COLLAGEN; EPIDERMAL GROWTH FACTOR; EXTRACELLULAR MATRIX; HEART VALVES; MODELS, BIOLOGICAL; PHENOTYPE; SWINE; TISSUE ENGINEERING; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84888440204     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.10.047     Document Type: Article

References (63)

1. Pedersen J.A., Swartz M.A. Mechanobiology in the third dimension. Ann Biomed Eng 2005, 33:1469-1490.
2. Kural M.H., Billiar K.L. Regulating tension in three-dimensional culture environments. Exp Cell Res 2013, 319(16):2447-2459.
3. Syedain Z.H., Lahti M.T., Johnson S.L., Robinson P.S., Ruth G.R., Bianco R.W., et al. Implantation of a tissue-engineered heart valve from human fibroblasts exhibiting short term function in the sheep pulmonary artery. Cardiovasc Eng Technol 2011, 2:101-112.
4. van Vlimmeren M.A., Driessen-Mol A., Oomens C.W., Baaijens F.P. Passive and active contributions to generated force and retraction in heart valve tissue engineering. Biomech Model Mechanobiol 2012, 11:1015-1027.
5. Tomasek J.J., Gabbiani G., Hinz B., Chaponnier C., Brown R.A. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 2002, 3:349-363.
6. Lundberg M.S. Cardiovascular tissue engineering research support at the National Heart, Lung, and Blood Institute. Circ Res 2013, 112:1097-1103.
7. Hoenig M.R., Campbell G.R., Rolfe B.E., Campbell J.H. Tissue-engineered blood vessels: alternative to autologous grafts?. Arteriocler Thromb Vacs Biol 2005, 25:1128-1134.
8. Gauvin R., Larouche D., Marcoux H., Guignard R., Auger F.A., Germain L. Minimal contraction for tissue-engineered skin substitutes when matured at the air-liquid interface. JTissue Eng Regen Med 2013, 7:452-460.
9. Roy-Chaudhury P., Kelly B.S., Miller M.A., Reaves A., Armstrong J., Nanayakkara N., et al. Venous neointimal hyperplasia in polytetrafluoroethylene dialysis grafts. Kidney Int 2001, 59:2325-2334.
10. van Vlimmeren M.A., Driessen-Mol A., Oomens C.W., Baaijens F.P. An invitro model system to quantify stress generation, compaction, and retraction in engineered heart valve tissue. Tissue Eng Part C Methods 2011, 17:983-991.
11. Schmidt D., Dijkman P.E., Driessen-Mol A., Stenger R., Mariani C., Puolakka A., et al. Minimally-invasive implantation of living tissue engineered heart valves: a comprehensive approach from autologous vascular cells to stem cells. JAm Coll Cardiol 2010, 56:510-520.
12. Rabkin E., Aikawa M., Stone J.R., Fukumoto Y., Libby P., Schoen F.J. Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation 2001, 104:2525-2532.
13. Hoerstrup S.P., Kadner A., Melnitchouk S., Trojan A., Eid K., Tracy J., et al. Tissue engineering of functional trileaflet heart valves from human marrow stromal cells. Circulation 2002, 106:I143-I150.
14. Schoen F.J. Evolving concepts of cardiac valve dynamics: the continuum of development, functional structure, pathobiology, and tissue engineering. Circulation 2008, 118:1864-1880.
15. Hinz B. Formation and function of the myofibroblast during tissue repair. JInvest Dermatol 2007, 127:526-537.
16. Hinz B., Mastrangelo D., Iselin C.E., Chaponnier C., Gabbiani G. Mechanical tension controls granulation tissue contractile activity and myofibroblast differentiation. Am J Pathol 2001, 159:1009-1020.
17. Quinlan A.M., Billiar K.L. Investigating the role of substrate stiffness in the persistence of valvular interstitial cell activation. JBiomed Mater Res A 2012, 100:2474-2482.
18. Hinz B., Celetta G., Tomasek J.J., Gabbiani G., Chaponnier C. Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol Biol Cell 2001, 12:2730-2741.
19. Chen J., Li H., SundarRaj N., Wang J.H. Alpha-smooth muscle actin expression enhances cell traction force. Cell Motil Cytoskeleton 2007, 64:248-257.
20. Han S.J., Bielawski K.S., Ting L.H., Rodriguez M.L., Sniadecki N.J. Decoupling substrate stiffness, spread area, and micropost density: a close spatial relationship between traction forces and focal adhesions. Biophys J 2012, 103:640-648.
21. Marinkovic A., Mih J.D., Park J.A., Liu F., Tschumperlin D.J. Improved throughput traction microscopy reveals pivotal role for matrix stiffness in fibroblast contractility and TGF-beta responsiveness. Am J Physiol Lung Cell Mol Physiol 2012, 303:L169-L180.
22. Goffin J.M., Pittet P., Csucs G., Lussi J.W., Meister J.J., Hinz B. Focal adhesion size controls tension-dependent recruitment of alpha-smooth muscle actin to stress fibers. JCell Biol 2006, 172:259-268.
23. Kloxin A.M., Benton J.A., Anseth K.S. In situ elasticity modulation with dynamic substrates to direct cell phenotype. Biomaterials 2010, 31:1-8.
24. Arora P.D., Narani N., McCulloch C.A. The compliance of collagen gels regulates transforming growth factor-beta induction of alpha-smooth muscle actin in fibroblasts. Am J Pathol 1999, 154:871-882.
25. Vaughan M.B., Howard E.W., Tomasek J.J. Transforming growth factor-beta1 promotes the morphological and functional differentiation of the myofibroblast. Exp Cell Res 2000, 257:180-189.
26. Inoue M., Ono I., Tateshita T., Kuroyanagi Y., Shioya N. Effect of a collagen matrix containing epidermal growth factor on wound contraction. Wound Repair Regen 1998, 6:213-222.
27. Murray M.M., Rice K., Wright R.J., Spector M. The effect of selected growth factors on human anterior cruciate ligament cell interactions with a three-dimensional collagen-GAG scaffold. JOrthop Res 2003, 21:238-244.
28. Grinnell F., Ho C.H. Transforming growth factor beta stimulates fibroblast-collagen matrix contraction by different mechanisms in mechanically loaded and unloaded matrices. Exp Cell Res 2002, 273:248-255.
29. Tuan T., Song A., Chang A., Younai S., Nimni M.E. Invitro fibroplasia: matrix contraction, cell growth, and collagen production of fibroblasts cultured in fibrin gels. Exp Cell Res 1996, 223:127-134.
30. Walker G.A., Masters K.S., Shah D.N., Anseth K.S., Leinwand L.A. Valvular myofibroblast activation by transforming growth factor-beta: implications for pathological extracellular matrix remodeling in heart valve disease. Circ Res 2004, 95:253-260.
31. Yao L., Swartz D.D., Gugino S.F., Russell J.A., Andreadis S.T. Fibrin-based tissue-engineered blood vessels: differential effects of biomaterial and culture parameters on mechanical strength and vascular reactivity. Tissue Eng 2005, 11:991-1003.
32. Roberts A.B., Sporn M.B., Assoian R.K., Smith J.M., Roche N.S., Wakefield L.M., et al. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis invivo and stimulation of collagen formation invitro. Proc Natl Acad Sci USA 1986, 83:4167-4171.
33. Neidert M.R., Lee E.S., Oegema T.R., Tranquillo R.T. Enhanced fibrin remodeling invitro with TGF-beta1, insulin and plasmin for improved tissue-equivalents. Biomaterials 2002, 23:3717-3731.
34. Grassl E.D., Oegema T.R., Tranquillo R.T. Afibrin-based arterial media equivalent. JBiomed Mater Res A 2003, 66:550-561.
35. Breen E.C. Mechanical strain increases type I collagen expression in pulmonary fibroblasts invitro. JAppl Physiol 2000, 88:203-209.
36. Parsons M., Kessler E., Laurent G.J., Brown R.A., Bishop J.E. Mechanical load enhances procollagen processing in dermal fibroblasts by regulating levels of procollagen C-proteinase. Exp Cell Res 1999, 252:319-331.
37. Yang G., Crawford R.C., Wang J.H. Proliferation and collagen production of human patellar tendon fibroblasts in response to cyclic uniaxial stretching in serum-free conditions. JBiomech 2004, 37:1543-1550.
38. Hinz B., Gabbiani G., Chaponnier C. The NH2-terminal peptide of alpha-smooth muscle actin inhibits force generation by the myofibroblast invitro and invivo. JCell Biol 2002, 157:657-663.
39. Hall M.S., Long R., Feng X., Huang Y., Hui C.-Y., Wu M. Toward single cell traction microscopy within 3D collagen matrices. Exp Cell Res 2013, 319(16):2396-2408.
40. Delvoye P., Wiliquet P., Leveque J.L., Nusgens B.V., Lapiere C.M. Measurement of mechanical forces generated by skin fibroblasts embedded in a three-dimensional collagen gel. JInvest Dermatol 1991, 97:898-902.
41. Kolodney M.S., Wysolmerski R.B. Isometric contraction by fibroblasts and endothelial cells in tissue culture: a quantitative study. JCell Biol 1992, 117:73-82.
42. John J., Quinlan A.T., Silvestri C., Billiar K. Boundary stiffness regulates fibroblast behavior in collagen gels. Ann Biomed Eng 2010, 38:658-673.
43. Boudou T., Legant W.R., Mu A., Borochin M.A., Thavandiran N., Radisic M., et al. Amicrofabricated platform to measure and manipulate the mechanics of engineered cardiac microtissues. Tissue Eng Part A 2012, 18:910-919.
44. Freyman T.M., Yannas I.V., Yokoo R., Gibson L.J. Fibroblast contraction of a collagen-GAG matrix. Biomaterials 2001, 22:2883-2891.
45. Throm Quinlan A.M., Sierad L.N., Capulli A.K., Firstenberg L.E., Billiar K.L. Combining dynamic stretch and tunable stiffness to probe cell mechanobiology invitro. PLoS One 2011, 6:e23272.
46. Legant W.R., Pathak A., Yang M.T., Deshpande V.S., McMeeking R.M., Chen C.S. Microfabricated tissue gauges to measure and manipulate forces from 3D microtissues. Proc Natl Acad Sci USA 2009, 106:10097-10102.
47. Ahlfors J.E., Billiar K.L. Biomechanical and biochemical characteristics of a human fibroblast-produced and remodeled matrix. Biomaterials 2007, 28:2183-2191.
48. Tranquillo R., Isenberg B. Artificial soft tissue fabrication from cell-contracted biopolymers. Functional tissue engineering 2003, 305-317. Springer, New York. F. Guilak, D. Butler, S. Goldstein, D. Mooney (Eds.).
49. Throm A.M., Liu W.C., Lock C.H., Billiar K.L. Development of a cell-derived matrix: effects of epidermal growth factor in chemically defined culture. JBiomed Mater Res A 2010, 92:533-541.
50. Grouf J.L., Throm A.M., Balestrini J.L., Bush K.A., Billiar K.L. Differential effects of EGF and TGF-beta1 on fibroblast activity in fibrin-based tissue equivalents. Tissue Eng 2007, 13:799-807.
51. Kershaw J.D., Misfeld M., Sievers H.H., Yacoub M.H., Chester A.H. Specific regional and directional contractile responses of aortic cusp tissue. JHeart Valve Dis 2004, 13:798-803.
52. Merryman D.W., Shadow H.S., Schoen F.J., Sacks M.S. The effects of cellular contraction on aortic valve leaflet flexural stiffness. JBiomech 2006, 39:88-96.
53. Ingber D.E., Prusty D., Sun Z., Betensky H., Wang N. Cell shape, cytoskeletal mechanics, and cell cycle control in angiogenesis. JBiomech 1995, 28:1471-1484.
54. Tamariz E., Grinnell F. Modulation of fibroblast morphology and adhesion during collagen matrix remodeling. Mol Biol Cell 2002, 13:3915-3929.
55. West A.R., Zaman N., Cole D.J., Walker M.J., Legant W.R., Boudou T., et al. Development and characterization of a 3D multicell microtissue culture model of airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2013, 304:L4-L16.
56. Cushing M.C., Liao J.-T., Anseth K.S. Activation of valvular interstitial cells is mediated by transforming growth factor-β1 interactions with matrix molecules. Matrix Biol 2005, 24:428-437.
57. Thermoscientific Growth factors in cell culture serum 2013, Retrieved 08.13.13, from. http://www.thermoscientific.com/ecomm/servlet/newsdetail%3fstoreId%3d11152%26contentId%3d56974.
58. Tomasek J.J., Haaksma C.J., Eddy R.J., Vaughan M.B. Fibroblast contraction occurs on release of tension in attached collagen lattices: dependency on an organized actin cytoskeleton and serum. Anat Rec 1992, 232:359-368.
59. Dijkman P.E., Driessen-Mol A., Frese L., Hoerstrup S.P., Baaijens F.P.T. Decellularized homologous tissue-engineered heart valves as off-the-shelf alternatives to xeno- and homografts. Biomaterials 2012, 33:4545-4554.
60. Weber B., Dijkman P.E., Scherman J., Sanders B., Emmert M.Y., Grünenfelder J., et al. Off-the-shelf human decellularized tissue-engineered heart valves in a non-human primate model. Biomaterials 2013, 34:7269-7280.
61. Flynn B.P., Bhole A.P., Saeidi N., Liles M., DiMarzio C.A., Ruberti J.W. Mechanical strain stabilizes reconstituted collagen fibrils against enzymatic degradation by mammalian collagenase matrix metalloproteinase 8 (MMP-8). PLoS ONE 2010, 5:e12337.
62. Chiquet M. Regulation of extracellular matrix gene expression by mechanical stress. Matrix Biol 1999, 18:417-426.
63. Butt R.P., Bishop J.E. Mechanical load enhances the stimulatory effect of serum growth factors on cardiac fibroblast procollagen synthesis. JMol Cell Cardiol 1997, 29:1141-1151.